Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Sjöstrand, M."'
Autor:
Kondo T; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan., Mogensen UM; Department of Cardiology, Zealand University Hospital, Roskilde, Denmark., Talebi A; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Gasparyan SB; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Campbell RT; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., de Boer RA; Erasmus Medical Center, Rotterdam, the Netherlands., Inzucchi SE; Yale School of Medicine, New Haven, Connecticut, USA., Køber L; Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark., Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, Missouri, USA., Martinez FA; University of Cordoba, Cordoba, Argentina., Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Bengtsson O; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Sjöstrand M; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address: john.mcmurray@glasgow.ac.uk.
Publikováno v:
Journal of the American College of Cardiology [J Am Coll Cardiol] 2024 May 21; Vol. 83 (20), pp. 1973-1986. Date of Electronic Publication: 2024 Mar 25.
Autor:
Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Simpson J; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Inzucchi SE; Section of Endocrinology, Yale University School of Medicine, New Haven, Connecticut, USA., Køber L; Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, Missouri, USA., Martinez FA; National University of Cordoba, Cordoba, Argentina., Ponikowski P; Wroclaw Medical University, Wroclaw, Poland., Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Bengtsson O; AstraZeneca, Gothenburg, Sweden., Sjöstrand M; AstraZeneca, Gothenburg, Sweden., Lindholm D; AstraZeneca, Gothenburg, Sweden., Langkilde AM; AstraZeneca, Gothenburg, Sweden., Solomon SD; Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address: john.mcmurray@glasgow.ac.uk.
Publikováno v:
JACC. Heart failure [JACC Heart Fail] 2022 Feb; Vol. 10 (2), pp. 104-118. Date of Electronic Publication: 2022 Jan 12.
Autor:
Berg DD; TIMI Study Group, Division of Cardiovascular Medicine (D.D.B., M.S.S., D.A.M.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Docherty KF; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland (K.F.D., N.S., P.W., P.S.J., J.J.V.M.)., Sattar N; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland (K.F.D., N.S., P.W., P.S.J., J.J.V.M.)., Jarolim P; Department of Pathology (P.J.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Welsh P; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland (K.F.D., N.S., P.W., P.S.J., J.J.V.M.)., Jhund PS; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland (K.F.D., N.S., P.W., P.S.J., J.J.V.M.)., Anand IS; University of Minnesota, Minneapolis (I.S.A.)., Chopra V; Max Superspeciality Hospital, Saket, New Delhi, India (V.C.)., de Boer RA; Department of Cardiology, University Medical Center Groningen, University of Groningen, The Netherlands (R.A.d.B.)., Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City (M.N.K.)., Nicolau JC; Instituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Brazil (J.C.N.)., O'Meara E; Department of Cardiology, Montreal Heart Institute and Université de Montréal, Canada (E.O.)., Schou M; Department of Cardiology, Herlev and Gentofte University Hospital, Denmark (M.S.).; AstraZeneca, Goteborg, Sweden (A.H., A.-M.L., D.L., M.S.)., Hammarstedt A; TIMI Study Group, Division of Cardiovascular Medicine (D.D.B., M.S.S., D.A.M.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Langkilde AM; AstraZeneca, Goteborg, Sweden (A.H., A.-M.L., D.L., M.S.)., Lindholm D; AstraZeneca, Goteborg, Sweden (A.H., A.-M.L., D.L., M.S.)., Sjöstrand M; AstraZeneca, Goteborg, Sweden (A.H., A.-M.L., D.L., M.S.)., McMurray JJV; British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland (K.F.D., N.S., P.W., P.S.J., J.J.V.M.)., Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine (D.D.B., M.S.S., D.A.M.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Morrow DA; TIMI Study Group, Division of Cardiovascular Medicine (D.D.B., M.S.S., D.A.M.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Publikováno v:
Circulation [Circulation] 2022 Jan 18; Vol. 145 (3), pp. 158-169. Date of Electronic Publication: 2021 Nov 08.
Autor:
Butt JH; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark (J.H.B., L.K.)., Adamson C; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (C.A., K.F.D., M.C.P., P.S.J., J.J.V.M.)., Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (C.A., K.F.D., M.C.P., P.S.J., J.J.V.M.)., de Boer RA; Department of Cardiology, University Medical Center and University of Groningen, the Netherlands (R.A.d.B.)., Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (C.A., K.F.D., M.C.P., P.S.J., J.J.V.M.)., Inzucchi SE; Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.)., Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City (M.N.K.).; The George Institute for Global Health, University of New South Wales, Sydney, Australia (M.N.K.)., Maria Langkilde A; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., D.L., O.B., M. Sjöstrand)., Lindholm D; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., D.L., O.B., M. Sjöstrand)., Martinez FA; Universidad Nacional de Córdoba, Córdoba, Argentina (F.A.M.)., Bengtsson O; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., D.L., O.B., M. Sjöstrand)., Schou M; Department of Cardiology, Herlev-Gentofte University Hospital, Herlev, Denmark (M. Schou)., O'Meara E; Montreal Heart Institute, Université de Montréal, Quebec, Canada (E.O.)., Ponikowski P; Center for Heart Diseases, University Hospital, Wroclaw Medical University, Poland (P.P.)., Sabatine MS; TIMI Study Group (M.S.S.), Brigham and Women's Hospital, Boston, MA.; Division of Cardiovascular Medicine (M.S.S., S.D.S.), Brigham and Women's Hospital, Boston, MA., Sjöstrand M; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., D.L., O.B., M. Sjöstrand)., Solomon SD; Division of Cardiovascular Medicine (M.S.S., S.D.S.), Brigham and Women's Hospital, Boston, MA., Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (C.A., K.F.D., M.C.P., P.S.J., J.J.V.M.)., McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (C.A., K.F.D., M.C.P., P.S.J., J.J.V.M.)., Køber L; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark (J.H.B., L.K.).
Publikováno v:
Circulation. Heart failure [Circ Heart Fail] 2021 Dec; Vol. 14 (12), pp. e008837. Date of Electronic Publication: 2021 Nov 22.
Autor:
Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Claggett B; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts., Ferreira JP; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; National Institute of Health and Medical Research, Center for Clinical Multidisciplinary Research 1433, INSERM U1116, Nancy, France., Bengtsson O; AstraZeneca R&D, Gothenburg, Sweden., Inzucchi SE; Section of Endocrinology, Yale University School of Medicine, New Haven, Connecticut., Køber L; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Kosiborod MN; Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City.; The George Institute for Global Health, University of New South Wales, Sydney, Australia., Langkilde AM; AstraZeneca R&D, Gothenburg, Sweden., Martinez FA; Universidad Nacional de Córdoba, Córdoba, Argentina., Ponikowski P; Center for Heart Diseases, Wroclaw Medical University, Wroclaw, Poland., Sabatine MS; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts., Sjöstrand M; AstraZeneca R&D, Gothenburg, Sweden., Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Publikováno v:
JAMA cardiology [JAMA Cardiol] 2021 Nov 01; Vol. 6 (11), pp. 1298-1305.
Autor:
Butt JH; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland., Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland., Schou M; Department of Cardiology, Herlev-Gentofte University Hospital, Herlev, Denmark., Kosiborod MN; St Luke's Mid America Heart Institute, University of Missouri-Kansas City.; The George Institute for Global Health, University of New South Wales, Sydney, Australia., O'Meara E; Department of Cardiology, Montreal Heart Institute, Montreal, Ontario, Canada., Katova T; Clinic of Cardiology, National Cardiology Hospital, Sofia, Bulgaria., Ljungman CEA; Department of Molecular and Clinical Medicine and Cardiology, Sahlgrenska Academy, Gothenburg, Sweden., Diez M; Division of Cardiology, Institute Cardiovascular de Buenos Aires, Buenos Aires, Argentina., Ogunniyi MO; Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia., Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Sjöstrand M; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Lindholm D; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Bengtsson O; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Martinez FA; Universidad Nacional de Córdoba, Córdoba, Argentina., Ponikowski P; Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wrocław, Poland., Sabatine MS; TIMI Study Group, Brigham and Women's Hospital, Boston, Massachusetts., Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland., McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, Scotland., Køber L; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Publikováno v:
JAMA cardiology [JAMA Cardiol] 2021 Jun 01; Vol. 6 (6), pp. 678-689.
Autor:
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.S.J., K.F.D., M.C.P., J.J.V.M.)., Ponikowski P; Center for Heart Diseases, University Hospital, Wroclaw Medical University, Poland (P.P.)., Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.S.J., K.F.D., M.C.P., J.J.V.M.)., Gasparyan SB; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (S.B.G., O.B., A.-M.L., M.S.)., Böhm M; The Department of Medicine, Saarland University Hospital, Homburg-Saar, Germany (M.B.)., Chiang CE; Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University, Taiwan (C.-E.C.)., Desai AS; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (A.S.D., S.D.S.)., Howlett J; Cumming School of Medicine and Libin Cardiovascular Institute, University of Calgary, Alberta, Canada (J.H.)., Kitakaze M; Cardiovascular Division of Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan (M.K.)., Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.S.J., K.F.D., M.C.P., J.J.V.M.)., Verma S; Division of Cardiac Surgery, St. Michael's Hospital, University of Toronto, Canada (S.V.)., Bengtsson O; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (S.B.G., O.B., A.-M.L., M.S.)., Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (S.B.G., O.B., A.-M.L., M.S.)., Sjöstrand M; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (S.B.G., O.B., A.-M.L., M.S.)., Inzucchi SE; Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.)., Køber L; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark (L.K.)., Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City (M.N.K.).; The George Institute for Global Health, University of New South Wales, Sydney, Australia (M.N.K.)., Martinez FA; Universidad Nacional de Córdoba, Argentina (F.A.M.)., Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (M.S.S.)., Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (A.S.D., S.D.S.)., McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.S.J., K.F.D., M.C.P., J.J.V.M.).
Publikováno v:
Circulation [Circulation] 2021 May 18; Vol. 143 (20), pp. 1962-1972. Date of Electronic Publication: 2021 Apr 09.
Autor:
Berg DD; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Murphy SA; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Verma S; Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Canada., Inzucchi SE; Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut., Køber L; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City, Missouri., Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden., Martinez FA; Universidad Nacional de Córdoba, Córdoba, Argentina., Bengtsson O; Late Stage Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden., Ponikowski P; Center for Heart Diseases, University Hospital, Wrocław Medical University, Poland., Sjöstrand M; Late Stage Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden., Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts., McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Publikováno v:
JAMA cardiology [JAMA Cardiol] 2021 May 01; Vol. 6 (5), pp. 499-507.
Autor:
Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.S.J., K.F.D., J.J.V.M.)., Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (S.D.S., A.S.D.)., Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.S.J., K.F.D., J.J.V.M.)., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology (H.J.L.H.), University Medical Center Groningen, University of Groningen, The Netherlands., Anand IS; Department of Cardiology, University of Minnesota, Minneapolis (I.S.A.)., Böhm M; Department of Medicine, Saarland University Hospital, Homburg-Saar, Germany (M.B.)., Chopra V; Department of Cardiology, Max Super Speciality Hospital, Saket, New Delhi, India (V.C.)., de Boer RA; Department of Cardiology (R.A.d.B.), University Medical Center Groningen, University of Groningen, The Netherlands., Desai AS; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (S.D.S., A.S.D.)., Ge J; Department of Cardiology, Shanghai Institute of Cardiovascular Disease and Zhongshan Hospital Fudan University, China (J.G.)., Kitakaze M; Cardiovascular Division of Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan (M.K.)., Merkley B; Heart and Vascular Center, Semmelweis University, Budapest, Hungary (B.M.)., O'Meara E; Department of Cardiology, Montreal Heart Institute, Canada (E.O.)., Shou M; Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark (M. Shou)., Tereshchenko S; Department of Myocardial Disease and Heart Failure, National Medical Research Center of Cardiology, Moscow, Russia (S.T.)., Verma S; Division of Cardiac Surgery, St. Michael's Hospital, University of Toronto, Canada (S.V.)., Vinh PN; Department of Internal Medicine, Tan Tao University, Tan Duc, Vietnam (P.N.V.)., Inzucchi SE; Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.)., Køber L; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark (L.K.)., Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City (M.N.K.).; The George Institute for Global Health, University of New South Wales, Sydney, Australia (M.N.K.)., Martinez FA; Universidad Nacional de Córdoba, Córdoba, Argentina (F.A.M.)., Ponikowski P; Center for Heart Diseases, University Hospital, Wroclaw Medical University, Poland (P.P.)., Sabatine MS; TIMI Study Group, Brigham and Women's Hospital, Boston, MA (M.S.S.)., Bengtsson O; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., A.M.L., M. Sjöstrand)., Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., A.M.L., M. Sjöstrand)., Sjöstrand M; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., A.M.L., M. Sjöstrand)., McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.S.J., K.F.D., J.J.V.M.).
Publikováno v:
Circulation [Circulation] 2021 Jan 26; Vol. 143 (4), pp. 298-309. Date of Electronic Publication: 2020 Oct 12.
Autor:
Yeoh SE; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., P.D., P.S.J., J.J.V.M.)., Dewan P; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., P.D., P.S.J., J.J.V.M.)., Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., P.D., P.S.J., J.J.V.M.)., Inzucchi SE; Section of Endocrinology, Yale University School of Medicine, New Haven, CT (S.E.I.)., Køber L; Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark (L.K.)., Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City (M.N.K.)., Martinez FA; National University of Cordoba, Argentina (F.A.M.)., Ponikowski P; Wroclaw Medical University, Poland (P.P.)., Sabatine MS; The TIMI Study Group (M.S.S.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Solomon SD; Cardiovascular Division (S.D.S.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Bengtsson O; AstraZeneca, Gothenburg, Sweden (O.B., M.S., A.M.L.)., Sjöstrand M; AstraZeneca, Gothenburg, Sweden (O.B., M.S., A.M.L.)., Langkilde AM; AstraZeneca, Gothenburg, Sweden (O.B., M.S., A.M.L.)., McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (S.E.Y., P.D., P.S.J., J.J.V.M.).
Publikováno v:
Circulation. Heart failure [Circ Heart Fail] 2020 Dec; Vol. 13 (12), pp. e007879. Date of Electronic Publication: 2020 Nov 09.